Chapter 15 Clinical pharmacokinetics of acetylcholinesterase inhibitors
- 1 January 1990
- book chapter
- Published by Elsevier
- Vol. 84, 139-143
- https://doi.org/10.1016/s0079-6123(08)60897-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Reversal of postoperative somnolence using a two‐rate infusion of physostigmineActa Anaesthesiologica Scandinavica, 1989
- Tetrahydroaminoacridine selectively attenuates NMDA receptor-mediated neurotoxicityEuropean Journal of Pharmacology, 1988
- Pharmacokinetics of physostigmine after intravenous, intramuscular and subcutaneous administration in surgical patientsActa Anaesthesiologica Scandinavica, 1986
- Clinical Pharmacokinetics of Cholinesterase InhibitorsClinical Pharmacokinetics, 1986
- Pyridostigmine kinetics in healthy subjects and patients with myasthenia gravisClinical Pharmacology & Therapeutics, 1985
- Clinical pharmacology of pyridostigmine and neostigmine in patients with myasthenia gravis.Journal of Neurology, Neurosurgery & Psychiatry, 1983
- The relationship of plasma levels of pyridostigmine to clinical effect in patients with myasthenia gravisJournal of Neurology, Neurosurgery & Psychiatry, 1981
- Pharmacokinetics and oral bioavailability of pyridostigmine in manEuropean Journal of Clinical Pharmacology, 1980
- A pharmacokinetic study of neostigmine in man using gas chromatography-mass spectrometryEuropean Journal of Clinical Pharmacology, 1979
- The pharmacokinetics of pyridostigmineNeurology, 1976